The global drug delivery devices market is currently estimated to be valued at USD 215 billion for the year 2016 and is expected to grow at a CAGR of approximately 9.3% CAGR from 2016 to 2021. Currently, North America dominates the global market owing to the fact that there is greater awareness and per capita incomes. The Asia-Pacific region is expected to show good growth in the future primarily due to the increased awareness among the population. The major trend driving the drug delivery devices market is the major need for controlled release of drugs.
This escalation is developing the need to analyze, review and forecast the growth of the drug delivery devices market. Owing to the rapid evolution in the use of injectable drug delivery technology, medical device companies that are able to launch new innovative equipment will be awarded huge benefits.
Global Injectable Drug Delivery Market- Market Dynamics
The report details several driving and restraining factors for the global injectable drug delivery market. Some of them are listed below.
The global drug delivery devices market is segmented on the basis of mode of delivery -Nasal (Nasal Drops, Nasal Sprays, Nasal Inhalers, and Others), Oral (Dissolution controlled systems, Diffusion-controlled systems, Osmotic pressure controlled systems, pH - independent formulations, Ion -exchange resin drug complexes, Slow dissolving salts & complexes, and Hydrodynamic pressure controlled system), Ocular (Eye Drops, Ointments & Gels, and Others), Implantable (Drug Eluting Stents, Contraceptives, Brachytherapy Seeds, and Intravitreal Implants), Injectable (Conventional Drug Delivery, and Self-Injected Drug Delivery), Transdermal, Topical, Pulmonary and Rectal) and on the basis of region (North America, Europe, Asia-Pacific & Rest of the World).
Some of the key players in the market are:
What the Report Offers